231-922-9460 | Google +

Showing posts with label michigan medicare. Show all posts
Showing posts with label michigan medicare. Show all posts

Tuesday, September 1, 2009

Sorting Fact From Fiction on Health Care

By The Wall Street Journal

In recent town-hall meetings, President Barack Obama has called for a national debate on health-care reform based on facts. It is fact that more than 40 million Americans lack coverage and spiraling costs are a burden on individuals, families and our economy. There is broad consensus that these problems must be addressed, especially Michigan Medicare. But the public is skeptical that their current clinical care is substandard and that no government bureaucrat will come between them and their doctor. Americans have good reason for their doubts—key assertions about gaps in care are flawed and reform proposals to oversee care could sharply shift decisions away from patients and their physicians.

Consider these myths and mantras of the current debate:

• Americans only receive 55% of recommended care. This would be a frightening statistic, if it were true. It is not. Yet it was presented as fact to the Senate Health and Finance Committees, which are writing reform bills, in March 2009 by the Agency for Healthcare Research and Quality (the federal body that sets priorities to improve the nation's health care).

The statistic comes from a flawed study published in 2003 by the Rand Corporation. That study was supposed to be based on telephone interviews with 13,000 Americans in 12 metropolitan areas followed up by a review of each person's medical records and then matched against 439 indicators of quality health practices. But two-thirds of the people contacted declined to participate, making the study biased. To make matters worse, there were incomplete medical records on many of those who participated and could not accurately document the care that these patients received.

Michigan Health Insurance and Michigan MedicareFor example, they found that only 15% of the patients had received a flu vaccine based on available medical records. But when asked directly, 85% of the patients said that they had been vaccinated. Most importantly, there were no data that indicated whether following the best practices defined by the experts made any difference in the health of the patients.

In March 2007, a team of researchers published a study that looked at nearly 10,000 patients at community health centers and assessed whether implementing similar quality measures would improve the health of patients with three costly disorders: diabetes, asthma and hypertension. It found that there was no improvement in any of these three maladies.

• The World Health Organization ranks the U.S. 37th In the world in quality. This is another frightening statistic. It is also not accurate. Yet the head of the National Committee for Quality Assurance, a powerful organization influencing both the government and private insurers in defining quality of care, has stated this as fact.

The World Health Organization ranks the U.S. No. 1 among all countries in "responsiveness." Responsiveness has two components: respect for persons (including dignity, confidentiality and autonomy of individuals and families to make decisions about their own care), and client orientation (including prompt attention, access to social support networks during care, quality of basic amenities and choice of Michigan health insurance provider). This is what Americans rightly understand as quality care and worry will be lost in the upheaval of reform. Our country's composite score fell to 37 primarily because we lack universal coverage and care is a financial burden for many citizens.

• We need to implement "best practices." Mr. Obama and his advisers believe in implementing "best practices" that physicians and hospitals should follow. A federal commission would identify these practices.

On June 24, 2009, the president appeared on "Good Morning America." When asked whether "best practices" would be implemented by "encouragement" or "by law," the president did not answer directly. He said that he was confident doctors "want to engage in best practices" and "patients are going to insist on it." The president also said there should be financial incentives to "allow doctors to do the right thing."

There are domains of medicine where a patient has no control and depends on the physician and the hospital to provide best practices. Strict protocols have been developed to prevent infections during procedures and to reduce the risk of surgical mishaps. There are also emergency situations like a patient arriving in the midst of a heart attack where standardized advanced treatments save many lives.

But once we leave safety measures and emergency therapies where patients have scant say, what is "the right thing"? Data from clinical studies provide averages from populations and may not apply to individual patients. Clinical studies routinely exclude patients with more than one medical condition and often the elderly or people on multiple medications. Conclusions about what works and what doesn't work change much too quickly for policy makers to dictate clinical practice.

An analysis of Internal Medicine in 2007 reveals how long it takes for conclusions derived from clinical studies about drugs, devices and procedures to become outdated. Within one year, 15 of 100 recommendations based on the "best evidence" had to be significantly reversed; within two years, 23 were reversed, and at 5 1/2 years, half were contradicted. Americans have witnessed these reversals firsthand as firm "expert" recommendations about the benefits of estrogen replacement therapy for postmenopausal women, low fat diets for obesity, and tight control of blood sugar were overturned.

Even when experts examine the same data, they can come to different conclusions. For example, millions of Americans have elevated cholesterol levels and no heart disease. Guidelines developed in the U.S. about whom to treat with cholesterol-lowering drugs are much more aggressive than guidelines in the European Union or the United Kingdom, even though experts here and abroad are extrapolating from the same scientific studies. An illuminating publication from researchers in Munich, Germany, published in March 2003 in the Journal of General Internal Medicine showed that of 100 consecutive patients seen in their clinic with high cholesterol, 52% would be treated with a statin drug in the U.S. based on our guidelines while only 26% would be prescribed statins in Germany and 35% in the U.K. So, different experts define "best practice" differently. Many prominent American cardiologists and specialists in preventive medicine believe the U.S. guidelines lead to overtreatment and the Europeans are more sensible. After hearing of this controversy, some patients will still want to take the drug and some will not.

This is how doctors and patients make shared decisions—by considering expert guidelines, weighing why other experts may disagree with the guidelines, and then customizing the therapy to the individual. With respect to "best practices," prudent doctors think, not just follow, and informed patients consider and then choose, not just comply.

• No government bureaucrat will come between you and your doctor. The president has repeatedly stated this in town-hall meetings. But his proposal to provide financial incentives to "allow doctors to do the right thing" could undermine this promise. If doctors and hospitals are rewarded for complying with government mandated treatment measures or penalized if they do not comply, clearly federal bureaucrats are directing health decisions.

Further, at the AMA convention in June 2009, the president proposed linking protection for physicians from malpractice lawsuits if they strictly adhered to government-sponsored treatment guidelines. We need tort reform, but this is misconceived and again clearly inserts the bureaucrat directly into clinical decision making. If doctors are legally protected when they follow government mandates, the converse is that doctors risk lawsuits if they deviate from federal guidelines—even if they believe the government mandate is not in the patient's best interest. With this kind of legislation, physicians might well pressure the patient to comply with treatments even if the therapy clashes with the individual's values and preferences.

The devil is in the regulations. Federal legislation is written with general principles and imperatives. The current House bill H.R. 3200 in title IV, part D has very broad language about identifying and implementing best practices in the delivery of health care. It rightly sets initial priorities around measures to protect patient safety. But the bill does not set limits on what "best practices" federal officials can implement. If it becomes law, bureaucrats could well write regulations mandating treatment measures that violate patient autonomy.

Private insurers are already doing this, and both physicians and patients are chafing at their arbitrary intervention. As Congress works to extend coverage and contain costs, any legislation must clearly codify the promise to preserve for Americans the principle of control over their health-care decisions, especially Michigan health insurance providers.

Drug Managers Should Keep Their Health

By The Wall Street Journal

They are the arteries of the prescription-drug network. Pharmacy-benefit managers earn billions pumping orders between drugstores, manufacturers, Michigan health insurance providers and Michigan Medicare. Can competition undermine their vitality?

With the Senate pressing benefit managers for more transparency, many fear that Michigan health insurance and prescription coverage could soon be squeezed by the private sector.

Just as important, benefit managers have scale that ensures they are able to manage prices. With control of a price list, benefit managers can save health-care providers money by pushing manufacturers for rebates.

Benefit managers also can tweak price lists if rebates don't justify a drug's expense. The cholesterol drug Lipitor was removed from a list of preferred treatments in 2006, prompting the Lipitor retail price to surge. But when patients switched to the generic substitute Zocor, treatment costs fell by hundreds of millions of dollars.

Thousands Spell Out End-of-Life Choices

By The News & Observer

The issue of end-of-life planning regularly creates emotional debate, as in the case of Terry Schiavo, a brain-damaged Florida resident who died in 2005, and in the current controversy about a U.S. House proposal to pay doctors through Michigan Medicare for talks with willing patients about how they want their lives to end.

The issue was hotly debated in 2007, when the legislature voted after bruising debate to revise end-of-life forms to provide more detailed choices for people planning ahead.

Michigan MedicareSince then, thousands of people have made the decision to spell out advance choices about how they should be treated as their final days near. Nursing homes, hospitals, hospices and other institutions have asked the state for more than 390,000end-of-life forms.

And about a dozen people each business day add their advance health-care choices in the form of documents that spell out what kinds of end-of-life care they want under specific conditions. Those are added to a separate online database of about 15,000 maintained by the office of Secretary of State. Total annual filings to the Advance Health Care Directive Registry are up nearly 50 percent during the last five years, records show.

People need to know, and tell their family, what their wishes are because there may be a time when they aren't able to do that. The divisions in a family that surround somebody's medical condition frequently are irreparable. Somebody will say, 'Mama said she didn't want to be kept alive this way,' and somebody else says, 'I never heard her say that.'"

Issue for families

This charged issue has gained such presence in the health-care debate that President Barack Obama had to repudiate claims last week that health-care reform would create "death panels" to pass judgment, based on age and infirmity, on who should live. Provisions for end-of-life consultations may be dropped by the U.S. Senate, while it remains in a pending version of the House health reform package.

But beyond the politics, the issue touches many families and can be more subtle, involving the deference that patients typically feel toward their doctors.

The problem is that everybody reveres their doctor. If the doctor suggests that it's time to take a cocktail pill or something, because of the esteem that people have for doctors, that could be devastating.

Two state forms -- DNR ("do not resuscitate") and MOST (medical order for scope of treatment) -- were designed to allow people to detail in advance how they want to be treated under various end-of-life scenarios.

Opponents said such documents would tend by their nature to encourage people to decide to forgo life-sustaining treatment.

Multiple hearings and votes on the bills were marked by emotional testimony and predictions of state-encouraged euthanasia. State Rep. Paul Stam, an Apex Republican, opposed the revised documents created by the 2007 legislation, but doesn't know whether they have resulted in older people being nudged in the direction of forgoing end-of-life care.

Figures from the state Office of Emergency Management Services, which produces and distributes the DNR and MOST forms, show that hospitals, nursing homes and home health agencies are among the groups requesting the largest numbers of forms. Although the orders from institutions don't necessarily mean each document is being filled out, repeat orders show that they are seeing plenty of use.

Monday, June 22, 2009

Obama Announces Agreement With Drug Companies
Story from USA Today

WASHINGTON (AP) — President Obama on Monday welcomed the pharmaceutical industry's agreement to help close a gap in Medicare's drug coverage including Michigan Medicare, calling the pact a step forward in the push for overhaul of the health care system.

Obama said that drug companies have pledged to spend $80 billion over the next decade to help reduce the cost of drugs for seniors and pay for a portion of Obama's health care legislation. The agreement with the pharmaceutical industry would help close a gap in prescription drug coverage under Medicare.

"This is a significant breakthrough on the road to health care reform, one that will make a difference in the lives of many older Americans," Obama said in the White House's Diplomatic Room.

Obama said the move will help correct an anomaly in the program that provides a prescription drug benefit through Medicare. Under the deal, drug companies will pay part of the cost of brand name drugs for lower and middle-income older people in the so-called "doughnut hole." That term refers to a feature of the current drug program that requires beneficiaries to pay the entire cost of prescriptions after initial coverage is exhausted but before catastrophic coverage begins.

"It's a reform that will make prescription drugs more affordable for millions of seniors and restore a measure of fairness," Obama said.

Obama said some Medicare Michigan beneficiaries will find at least a 50% discount on prescription drugs. Obama says drug companies stand to benefit when more Americans can afford prescription drugs.

The drug companies' investment would reduce the cost of drugs for seniors and pay for a portion of Obama's proposed revamping of health care. The deal was struck with Sen. Max Baucus, D-Mont., the chairman of the Senate Finance Committee, as well as the White House.

The president was joined Monday in announcing the deal by Barry Rand, head of the senior citizens' advocacy group AARP, as well as Baucus and Sen. Chris Dodd, D-Conn.

"This is an early win for reform," Rand said.